Perioperative Risk Factors for Overall Survival of Patients with Pancreatic Ductal Adenocarcinoma Underwent Laparoscopic Pancreaticoduodenectomy

Overview

Journal Updates Surg

Date 2025 Jan 20

PMID 39833516

Authors

Jing Zhang

He Cai

Man Zhang

Yunqiang Cai

Bing Peng

Affiliations

Soon will be listed here.

Abstract

The postoperative overall survival of patients with pancreatic ductal adenocarcinoma is not optimal. The aim of this study was to explore the perioperative risk factors for overall survival after laparoscopic pancreaticoduodenectomy (LPD) in patients with pancreatic ductal adenocarcinoma (PDAC). From January 2015 to January 2022, consecutive patients who underwent LPD with a pathological diagnosis of PDAC at our center were included in the study. LASSO regression and multivariate Cox regression were used to explore perioperative risk factors associated with overall survival. A total of 159 patients were included in the study. The median overall survival was 21 months. In the multivariate analysis, the level of direct bilirubin in serum (HR: 1.01, 95% CI 1.00-1.02, P = 0.043), postoperative pancreatic fistula (HR: 0.36, 95% CI 0.18-0.86, P = 0.010), and adjuvant therapy after surgery within 12 weeks (HR: 0.53, 95% CI 0.34-0.83, P = 0.001) were identified as independent risk factors associated with overall survival. A high level of direct bilirubin in the serum, happened with postoperative pancreatic fistula and delayed postoperative adjuvant therapy are prognostic risk factors affecting the overall survival of patients with PDAC after LPD.

References

Peng J, Sun B, Chen C, Zhou J, Chen Y, Chen H . Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma. Cell Res. 2019; 29(9):725-738. PMC: 6796938. DOI: 10.1038/s41422-019-0195-y. View

Neoptolemos J, Kleeff J, Michl P, Costello E, Greenhalf W, Palmer D . Therapeutic developments in pancreatic cancer: current and future perspectives. Nat Rev Gastroenterol Hepatol. 2018; 15(6):333-348. DOI: 10.1038/s41575-018-0005-x. View

Yin T, Qin T, Wei K, Shen M, Zhang Z, Wen J . Comparison of safety and effectiveness between laparoscopic and open pancreatoduodenectomy: A systematic review and meta-analysis. Int J Surg. 2022; 105:106799. DOI: 10.1016/j.ijsu.2022.106799. View

Sattari S, Sattari A, Makary M, Hu C, He J . Laparoscopic Versus Open Pancreatoduodenectomy in Patients With Periampullary Tumors: A Systematic Review and Meta-analysis. Ann Surg. 2022; 277(5):742-755. DOI: 10.1097/SLA.0000000000005785. View

Umemura A, Nitta H, Takahara T, Hasegawa Y, Sasaki A . Current status of laparoscopic pancreaticoduodenectomy and pancreatectomy. Asian J Surg. 2016; 41(2):106-114. DOI: 10.1016/j.asjsur.2016.09.003. View

Liu M, Ji S, Xu W, Liu W, Qin Y, Hu Q . Laparoscopic pancreaticoduodenectomy: are the best times coming?. World J Surg Oncol. 2019; 17(1):81. PMC: 6511193. DOI: 10.1186/s12957-019-1624-6. View

Olakowski M, Grudzinska E . Pancreatic head cancer - Current surgery techniques. Asian J Surg. 2022; 46(1):73-81. DOI: 10.1016/j.asjsur.2022.05.117. View

Cameron J, He J . Two thousand consecutive pancreaticoduodenectomies. J Am Coll Surg. 2015; 220(4):530-6. DOI: 10.1016/j.jamcollsurg.2014.12.031. View

Winer L, Dhar V, Wima K, Morris M, Lee T, Shah S . The Impact of Tumor Location on Resection and Survival for Pancreatic Ductal Adenocarcinoma. J Surg Res. 2019; 239:60-66. DOI: 10.1016/j.jss.2019.01.061. View

10.

Kardosh A, Lichtensztajn D, Gubens M, Kunz P, Fisher G, Clarke C . Long-Term Survivors of Pancreatic Cancer: A California Population-Based Study. Pancreas. 2018; 47(8):958-966. PMC: 6095724. DOI: 10.1097/MPA.0000000000001133. View

11.

Ferrone C, Pieretti-Vanmarcke R, Bloom J, Zheng H, Szymonifka J, Wargo J . Pancreatic ductal adenocarcinoma: long-term survival does not equal cure. Surgery. 2012; 152(3 Suppl 1):S43-9. PMC: 3806092. DOI: 10.1016/j.surg.2012.05.020. View

12.

Shin S, Kim S, Hong S, Song K, Lee J, Park K . Can statistically determined prognostic factors predict the long-term survival of patients with pancreatic ductal adenocarcinoma following surgical resection?: Clinicopathological analysis of 82 long-term survivors. Pancreas. 2014; 43(4):571-7. DOI: 10.1097/MPA.0000000000000063. View

13.

Yamamoto T, Yagi S, Kinoshita H, Sakamoto Y, Okada K, Uryuhara K . Long-term survival after resection of pancreatic cancer: a single-center retrospective analysis. World J Gastroenterol. 2015; 21(1):262-8. PMC: 4284344. DOI: 10.3748/wjg.v21.i1.262. View

14.

Stark A, Sacks G, Rochefort M, Donahue T, Reber H, Tomlinson J . Long-term survival in patients with pancreatic ductal adenocarcinoma. Surgery. 2016; 159(6):1520-1527. PMC: 4856542. DOI: 10.1016/j.surg.2015.12.024. View

15.

Shi S, Hua J, Liang C, Meng Q, Liang D, Xu J . Proposed Modification of the 8th Edition of the AJCC Staging System for Pancreatic Ductal Adenocarcinoma. Ann Surg. 2018; 269(5):944-950. DOI: 10.1097/SLA.0000000000002668. View

16.

Bassi C, Marchegiani G, Dervenis C, Sarr M, Abu Hilal M, Adham M . The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After. Surgery. 2017; 161(3):584-591. DOI: 10.1016/j.surg.2016.11.014. View

17.

Wente M, Bassi C, Dervenis C, Fingerhut A, Gouma D, Izbicki J . Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2007; 142(5):761-8. DOI: 10.1016/j.surg.2007.05.005. View

18.

Wente M, Veit J, Bassi C, Dervenis C, Fingerhut A, Gouma D . Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery. 2007; 142(1):20-5. DOI: 10.1016/j.surg.2007.02.001. View

19.

Li Y, Cai Y, Wang X, Meng L, Cai H, Xu J . [Optimization of Operative Procedure in Total Laparoscopic Pancreaticoduodenectomy (with Video)]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2020; 51(4):446-452. DOI: 10.12182/20200760108. View

20.

Cai H, Wang Y, Cai Y, Wang X, Ouyang G, Li Y . The Effect of Age on Short- and Long-Term Outcomes in Patients With Pancreatic Ductal Adenocarcinoma Undergoing Laparoscopic Pancreaticoduodenectomy. Pancreas. 2020; 49(8):1063-1068. DOI: 10.1097/MPA.0000000000001620. View